Surgical Outcomes With Neoadjuvant Durvalumab Plus Chemotherapy Followed by Adjuvant Durvalumab in Resectable NSCLC

作者：Tetsuya Mitsudomi, John V. Heymach, Martin Reck, Janis M. Taube, Shugeng Gao, Yoshitsugu Horio, Jian You, Gaofeng Li, Dinh Van Luong, Somcharoen Saeteng, Fumihiro Tanaka, Stefan Watzka, László Urbán, Zsuzsanna Szalai, Hiroaki Akamatsu, Jin Hyoung Kang, Francisco J. Orlandi, Guzel Mukhametshina, Andreas Pircher, Carlos Henrique Andrade Teixeira, Mike Aperghis, Gary J. Doherty, R Doake, Tamer M. Fouad, David H. Harpole · 发表于：Journal of Thoracic Oncology · 年份：2025 · DOI：10.1016/j.jtho.2025.06.015 · 被引用次数：23 · 研究领域：Lung Cancer Diagnosis and Treatment、Esophageal Cancer Research and Treatment、Cancer Immunotherapy and Biomarkers